Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Nov-Dec;50(6):302-308.
doi: 10.4103/ijp.IJP_452_17.

Management of myasthenia gravis during pregnancy

Ramandeep Bansal  1 , Manoj Kumar Goyal  2 , Manish Modi  2
Affiliations
Review

Management of myasthenia gravis during pregnancy

Ramandeep Bansal et al. Indian J Pharmacol. 2018 Nov-Dec.

Abstract

The management of myasthenia gravis (MG) during pregnancy requires special skills as both diseases as well as its treatment can have deleterious effects on mother and fetus. MG often affects women in second and third decades of life during the childbearing age. Exacerbations of MG are likely to occur during the first trimester and postpartum period. The treatment of MG during pregnancy needs to be individualized depending on the severity of MG as well as the efficacy of various treatment modalities and their possible harmful effects on pregnancy. In addition, special attention has to be given to avoid drugs and other factors (such as urinary tract infections) which may worsen MG. The key to successful outcome during pregnancy in myasthenic women lies in multidisciplinary care involving obstetricians, neurologists, anesthetist as well as neonatologist. In this review, we discuss various therapeutic options available for the management of MG during pregnancy and provide recommendations based on the current best evidence.

Keywords: Azathioprine; myasthenia; pregnancy; pyridostigmine; steroids.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Gilhus NE. Myasthenia gravis. N Engl J Med. 2016;375:2570–81. - PubMed
    1. Carr AS, Cardwell CR, McCarron PO, McConville J. A systematic review of population based epidemiological studies in myasthenia gravis. BMC Neurol. 2010;10:46. - PMC - PubMed
    1. Ferrero S, Esposito F, Biamonti M, Bentivoglio G, Ragni N. Myasthenia gravis during pregnancy. Expert Rev Neurother. 2008;8:979–88. - PubMed
    1. Ferrero S, Pretta S, Nicoletti A, Petrera P, Ragni N. Myasthenia gravis: Management issues during pregnancy. Eur J Obstet Gynecol Reprod Biol. 2005;121:129–38. - PubMed
    1. Da Silva FC, do Cima LC, de Sa RA. Myasthenia gravis and pregnancy. In: Minagar A, editor. Neurological Disorders and Pregnancy. Burlington, MA: Elsevier; 2011. pp. 55–68.

MeSH terms